The Independent Voice of
European Private Equity

Advanced Search

Advent-backed BioDuro acquires Sundia

Simon Thompson 25 September 2020

Active Pharmaceutical Ingredients
  • Advent led the investment in Sundia, with Bridgewest Capital co-investing.
  • The combined company will operate as BioDuro-Sundia and provide integrated drug discovery, development and manufacturing for active...

Related Articles

Goodwin hires Travers Smith duo

26/04/24

IK Partners raises maiden continuation fund

26/04/24

BC Partners partially exits pharma CDMO Aenova Group in trade sale

26/04/24

BGF backs UK-based human risk management platform with £3.25m

25/04/24

Nexxus Iberia marks debut investment from second fund

25/04/24

Mutares acquires majority stake in Sofinter

25/04/24